Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 4, 2006, Pages 810-816

  Colás, Carlos ^a   Monzón, Susana ^a   Venturini, Mónica ^a   Lezaun, Apolinar ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

allergens; allergic rhinitis and asthma; immunotherapy; Salsola kali; Zaragoza

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; GLUTARALDEHYDE; LORATADINE; PLACEBO; PLANT EXTRACT; POLLEN ANTIGEN; POLYMER; PREDNISOLONE; SALSOLA KALI EXTRACT; STEROID; UNCLASSIFIED DRUG; ALLERGEN;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; POLLEN; POLYMERIZATION; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SALSOLA; SALSOLA KALI; SENSITIVITY ANALYSIS; SKIN SENSITIVITY; SKIN TEST; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS NODULE; SYMPTOM; VACCINATION REACTION; ADOLESCENT; ALLERGIC CONJUNCTIVITIS; DESENSITIZATION; HAY FEVER; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; SAFETY;

ADOLESCENT; ADULT; ALLERGENS; ASTHMA; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; GLUTARAL; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SAFETY; SALSOLA;

EID: 33646934368     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.11.039     Document Type: Article

References (42)

1. Karawya M.S., Wassel G.M., Baghdadi H.H., and Ahmed Z. Phytochemical study of certain Salsola species. Planta Med 21 (1972) 173-176
2. Crimi N., Palermo B., Palermo F., Pistorio M.P., Rizza S., Mistretta A., et al. On the pollen morphology and frequency of allergic sensitization in Sicily of the genus Salsola L. (Chaenopodiaceae). Allergol Immunopatol 16 (1988) 259-262
3. Beatley J.C. Russian-thistle (Salsola) species in western United States. J Range Manage 26 (1973) 225-226
4. Lomson R.W., and Watry A. The importance of the Chenopodiaceae in pollinosis: with special reference to Winslow and Holbrook, Arizona. J Allergy 4 (1933) 225-281
5. Shafiee A., Jamali F., and Bayat B. Clinical significance of total serum IgE determination in screening of Iranian Russian thistle pollen hypersensitive individuals. Clin Allergy 10 (1980) 111-114
6. Gómez J., Mansfield L., Frederick R., and Rael E. Analysis of the individual allergens of Russian thistle pollen by an enzyme-linked immunoblotting technique. J Asthma 26 (1989) 243-250
7. Würtzen P.A., Nelson H.S., Lowenstein H., and Ipsen H. Characterization of Chenopodiales (Amaranthus retroflexus, Chenopodium album, Kochia scoparia, Salsola pestifer) pollen allergens. Allergy 50 (1995) 489-497
8. Shafiee A., Yunginger J.W., and Gleich G.J. Isolation and characterization of Russian thistle (Salsola pestifer) pollen allergens. J Allergy Clin Immunol 67 (1981) 472-481
9. Carnés J., Fernández-Caldas E., Marina A., Alonso C., Lahoz C., Colas C., et al. Immunochemical characterization of Russian thistle (Salsola kali) pollen extracts: purification of the allergen Sal k 1. Allergy 58 (2003) 1152-1156
10. Lobera T., and Blasco A. Estudio de polinosis en La Rioja. Rev Esp Alergol Inmunol Clin 13 (1998) 102-106
11. Lombardero M., Duffort O., Sellés J.G., Hernández J., and Carreira J. Cross-reactivity among Chenopodiaceae and Amaranthaceae. Ann Allergy 54 (1985) 430-436
12. Vallverdú A., García Ortega P., Martínez J., Martínez A., Esteban M.I., Molina M., et al. Mercurialis annua: characterization of main allergens and cross-reactivity with other species. Int Arch Allergy Immunol 112 (1997) 356-364
13. de la Hoz B. Rinoconjuntivitis y asma por hipersensibilidad al polen de Salsola kali (Chenopodiaceae): aspectos clínico-inmunológicos y valoración de la inmunoterapia (1995), Facultad de Medicina, Universidad Autónoma de Madrid, Madrid
14. Garde J., Ferrer A., Jover V., Pagan J.A., Andreu C., Abellan A., et al. Tolerance of a Salsola kali extract standardized in biological units administered by subcutaneous route: multicenter study. Allergol Immunopathol (Madr) 33 (2005) 100-104
15. Position paper: allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology. Allergy 48 suppl 14 (1993) 48-82
16. Immunotherapy Subcommittee of the European Academy of Allergology and Clinical Immunology. Immunotherapy: position paper. Allergy 48 suppl (1993) 7-30
17. Berrens L, inventor. A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use. International patent application PCT. #WO 94/06821. March 31, 1994
18. Álvarez-Cuesta E., Aragoneses-Gilsanz E., Martín-Garcia C., Berges-Gimeno P., González-Mancebo E., and Cuesta-Herranz J. Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life. Clin Exp Allergy 35 (2005) 572-578
19. Ameal A., Vega-Chicote J.M., Fernández S., Miranda A., Carmona M.J., Rondón M.C., et al. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma. Allergy 60 (2005) 1178-1183
20. Council of Europe. Allergen products (1063). European Pharmacopeia. 3rd ed. (1997), Council of Europe, Strasbourg, France
21. Mosbech H., Dreborg S., Frolund L., Ljungstedt-Pahlman I., Svendsen U.G., Soborg M., et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract, I: clinical effect evaluated by diary cards and a retrospective assessment. Allergy 44 (1989) 487-498
22. Nordic Council on Medicines. Registration of allergen preparations. Nordic guidelines. NLN publication no 23. 2nd ed. (1989), Nordic Council on Medicine, Uppsala, Sweden
23. Juniper E.F., Thompson A.K., Ferrie P.J., and Roberts J.N. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 104 (1999) 364-369
24. Juniper E.F., Guyatt G.H., Willan A., and Griffith L.E. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 47 (1994) 81-87
25. Juniper E.F., Guyatt G.H., Griffith L.E., and Ferrie P.J. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 98 (1996) 843-845
26. Álvarez Cuesta E., Boquete M., Cadahía A., Carrillo T., Fernández-Távora L., Hernández J., et al. Sociedad Española de Alergología e Inmunología Clínica. Normativa sobre Inmunoterapia en Enfermedades Alérgicas (1990), SANED, Madrid
27. Malling H.J., and Weeke B. EAACI position paper: immunotherapy. Allergy 48 (1993) 7-35
28. Finney D.J. Statistical methods in biological assay. 2nd ed. (1964), Hafner, New York
29. Bodtger U., Poulsen L.K., Jacobi H.H., and Malling H.J. The safety and efficacy of subcutaneous birch pollen immunotherapy: a one-year, randomised, double-blind, placebo-controlled study. Allergy 57 (2002) 297-305
30. Rafizadeh B. Demonstration of the blocking antibodies after immunotherapy with Russian thistle. In: Csaba B, Leövey A, Szemere P, editors. Proceedings of the XIII Congress EAACI; 1986 May 4-10; Budapest, Hungary. Debrecen: Alföldi Ny; 1986
31. Wurtzen P.A., Nelson H.S., Lowenstein H., and Ipsen H. Characterization of Chenopodiales (Amaranthus retroflexus, Chenopodium album, Kochia scoparia, Salsola pestifer) pollen allergens. Allergy 50 (1995) 489-497
32. Frostad A.B., Grimmer O., Sandvik L., Moxnes A., and Aas K. Clinical effects of hyposensitization using a purified allergen preparation from Timothy pollen as compared to crude aqueous extracts from Timothy pollen and a four-grass pollen mixture respectively. Clin Allergy 13 (1983) 337-357
33. Branco Ferreira M., Spinola Santos A., Pereira Santos M.C., Palma Carlos M.L., Pereira Barbosa M.A., and Palma Carlos A.G. Efficacy and safety of specific immunotherapy with a modified mite extract. Allergol Immunopathol (Madr) 33 (2005) 80-85
34. Ferrer A., and Garcia-Selles J. Significant improvement in symptoms, skin test, and specific bronchial reactivity after 6 months of treatment with a depigmented, polymerized extract of Dermatophagoides pteronyssinus and D. farinae. J Investig Allergol Clin Immunol 13 (2003) 244-251
35. Guerra F., Daza J.C., and Almeda E. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment. J Investig Allergol Clin Immunol 13 (2003) 108-117
36. García-Selles J., Pascual A., Funes E., Pagan J.A., Lopez J.D., Negro J.M., et al. Clinical efficacy and safety of a depigmented and glutaraldehyde polymerized therapeutic vaccine of Parietaria judaica. Allergol Immunopathol (Madr) 31 (2003) 63-69
37. Casanovas M., Fernández-Caldas E., Alamar R., and Basomba A. Comparative study of tolerance between unmodified and high doses of chemically modified allergen vaccines of Dermatophagoides pteronyssinus. Int Arch Allergy Immunol 137 (2005) 211-218
38. Casanovas M., Sastre J., Fernández-Nieto M., Lluch M., Carnés J., and Fernández-Caldas E. Double blind study of tolerability and antibody production of unmodified and chemically modified allergen vaccines of Phleum pratense. Clin Exp Allergy 35 (2005) 1377-1383
39. Casanovas M., Gomez M.J., Carnes J., and Fernández-Caldas E. Skin tests with native, depigmented and glutaraldehyde polymerized allergen extracts. J Investig Allergol Clin Immunol 15 (2005) 30-36
40. Frost L., Johansen P., Pedersen S., Veien N., Ostergaard P.A., and Nielsen M.H. Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts. Allergy 40 (1985) 368-372
41. Juniper E.F., Guyatt G.H., Andersson B., and Ferrie P.J. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy 70 (1993) 225-230
42. Spitzer W.O. State of science 1986: quality of life and functional status as target variables for research. J Chronic Dis 40 (1987) 465-471